Pimavanserin approved for Parkinson's-related hallucinations, delusions.
Kate
K
Traynor
D000978:Antiparkinson Agents / Q000627:therapeutic use*; D003702:Delusions / Q000188:drug therapy* / Q000209:etiology; D017277:Drug Approval / Q000379:methods; D004348:Drug Labeling / Q000592:standards; D006212:Hallucinations / Q000188:drug therapy* / Q000209:etiology; D006801:Humans; D010300:Parkinson Disease / Q000150:complications / Q000188:drug therapy*; D010880:Piperidines / Q000627:therapeutic use*; D014508:Urea / Q000031:analogs & derivatives* / Q000627:therapeutic use
D000978:Antiparkinson Agents; D010880:Piperidines; D014508:Urea; C510793:pimavanserin